Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy

Abstract
The introduction of expensive but very effective antiviral medications has led to questions about the effects on the total use of resources for the care of patients with human immunodeficiency virus (HIV) infection. We examined expenditures for the care of HIV-infected patients since the introduction of highly active antiretroviral therapy.